Skip to main content

Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.

Publication ,  Journal Article
Scarlett, UK; Conejo-Garcia, JR
Published in: Expert Rev Obstet Gynecol
September 1, 2012

After more than 30 years of iterations of surgical debulking plus chemotherapy, the need for complementary ovarian cancer treatments has become clear. In the ovarian cancer microenvironment, myeloid immunosuppressive leukocytes, lymphocytes, fibroblasts and endothelial cells, as well as their secreted products, surface molecules and paracrine survival factors, all provide opportunities for novel interventions. The potential of targeting microenvironmental elements in ovarian cancer patients is underscored by recently successful anti-angiogenic therapies. The compartmentalized nature of ovarian cancer, its immunogenicity and its accessibility make it an ideal disease for targeting non-tumor host cells. This review discusses the 'state-of-the-art' of the field, with an emphasis on the potential of modulating the activity of abundant microenvironmental immune cells, which govern both angiogenesis and immunosuppression.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Expert Rev Obstet Gynecol

DOI

ISSN

1747-4108

Publication Date

September 1, 2012

Volume

7

Issue

5

Start / End Page

413 / 419

Location

England

Related Subject Headings

  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Scarlett, U. K., & Conejo-Garcia, J. R. (2012). Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. Expert Rev Obstet Gynecol, 7(5), 413–419. https://doi.org/10.1586/eog.12.41
Scarlett, Uciane K., and Jose R. Conejo-Garcia. “Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.Expert Rev Obstet Gynecol 7, no. 5 (September 1, 2012): 413–19. https://doi.org/10.1586/eog.12.41.
Scarlett UK, Conejo-Garcia JR. Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. Expert Rev Obstet Gynecol. 2012 Sep 1;7(5):413–9.
Scarlett, Uciane K., and Jose R. Conejo-Garcia. “Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy.Expert Rev Obstet Gynecol, vol. 7, no. 5, Sept. 2012, pp. 413–19. Pubmed, doi:10.1586/eog.12.41.
Scarlett UK, Conejo-Garcia JR. Modulating the tumor immune microenvironment as an ovarian cancer treatment strategy. Expert Rev Obstet Gynecol. 2012 Sep 1;7(5):413–419.

Published In

Expert Rev Obstet Gynecol

DOI

ISSN

1747-4108

Publication Date

September 1, 2012

Volume

7

Issue

5

Start / End Page

413 / 419

Location

England

Related Subject Headings

  • 3215 Reproductive medicine
  • 1114 Paediatrics and Reproductive Medicine